<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Pathol. Oncol. Res.</journal-id>
<journal-title>Pathology &#x26; Oncology Research</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Pathol. Oncol. Res.</abbrev-journal-title>
<issn pub-type="epub">1532-2807</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">609620</article-id>
<article-id pub-id-type="doi">10.3389/pore.2021.609620</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Society Journal Archive</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Wnt3a/&#x3b2;-Catenin/CBP Activation in the Progression of Cervical Intraepithelial Neoplasia</article-title>
<alt-title alt-title-type="left-running-head">Feng et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Wnt Activation in the Progression of CIN</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Dingqing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lin</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wenhui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1070434/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Keqin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Haiyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Huan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ling</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1095925/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Department of Pathology, China-Japan Friendship Hospital, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Chinese Academy of Medical Sciences and Peking Union Medical College, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1002497/overview">L&#xe1;szl&#xf3; Kopper</ext-link>, Semmelweis University, Hungary</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Bin Ling, <email>lingbin.ling@vip.sina.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>03</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>27</volume>
<elocation-id>609620</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>09</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>02</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Feng, Lin, Wang, Yan, Liang, Liang, Yu and Ling.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Feng, Lin, Wang, Yan, Liang, Liang, Yu and Ling</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Piwil2 reprograms HPV-infected reserve cells in the cervix into tumor-initiated cells (TICs) and upregulates Wnt3a expression sequentially, which leads to cervical intraepithelial neoplasia (CIN) and ultimately squamous cell carcinoma (SCC). However, little is known regarding Wnt signaling in the maintenance of TIC stemness during the progression of cervical lesions. We herein investigated the expression of canonical Wnt3a signaling and related genes by microarray data set analysis and immunohistochemical (IHC) staining of samples obtained by biopsy of normal cervix, low- and high-grade CIN, and invasive SCC tissue. Array data analyzed by GEO2R showed higher expression levels of Wnt signaling and their target genes<italic>,</italic> significant upregulation of stemness-associated markers, and notably downregulated cell differentiation markers in CIN and SCC tissues compared with those in the normal cervix tissue. Further, Gene Set Enrichment Analysis (GSEA) revealed that Wnt pathway-related genes significantly enriched in SCC. IHC staining showed gradually increased immunoreactivity score of Wnt3a and CBP and notable translocation of <italic>&#x3b2;</italic>-catenin from the membrane to the cytoplasm and nucleus during the lesion progression. The intensity and proportion of P16, Ki67 and CK17 staining also increased with the progression of cervical lesions, whereas minimal to negative Involucrin expression was observed in CIN2/3 and SCC. Therefore, canonical Wnt signaling may contribute to the progression of CIN to SCC and may be a potential therapeutic target.</p>
</abstract>
<kwd-group>
<kwd>cervical intraepithelial neoplasia</kwd>
<kwd>wnt signaling</kwd>
<kwd>CBP</kwd>
<kwd>Piwil2</kwd>
<kwd>stemness</kwd>
<kwd>Differentiation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Cervical cancer is among the most preventable human malignancies, yet it remains a leading cause of death among women worldwide, accounting for more than 300,000 deaths annually [<xref ref-type="bibr" rid="B1">1</xref>]. In 2015, an estimated 98,900 new cases of invasive cervical cancer were diagnosed, and 30,500 women in China died from this cancer [<xref ref-type="bibr" rid="B2">2</xref>]. High-risk human papillomavirus (HR-HPV) is the major cause of cervical cancer, and in the precursor stages of cervical intraepithelial neoplasia (CIN, graded 1-3 according to severity), viral oncoprotein E6 and E7 targeting and degradation of P53 and retinoblastoma protein (pRb) lead to cell transformation, telomerase activation, and immortalization of the infected cells [<xref ref-type="bibr" rid="B3">3</xref>]. Further, it has been reported that E6 and E7 initiate the expression of Piwil2, which reactivates multiple germline factors of <italic>c-Myc</italic>, <italic>Klf4</italic>, <italic>Sox2</italic>, <italic>Nanog</italic>, and <italic>Oct4</italic> and reprograms HR-HPV-infected cells to tumor-initiating cells (TICs) [<xref ref-type="bibr" rid="B4">4</xref>]. The regulation of TIC stemness and differentiation plays a pivotal role in the progression of CIN to invasive cancer. However, the precise mechanism remains to be determined.</p>
<p>Wnts are secreted cysteine-rich glycoproteins that act as short-range ligands to locally activate receptor-mediated signaling pathways [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>]. A key step in the activation of Wnt target genes is the formation of a complex of <italic>&#x3b2;</italic>-catenin with members of the T-cell transcription factor (TCF)/lymphoid enhancer-binding factor (LEF) family of transcription factors [<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>]. To generate a transcriptionally active complex, TCF/&#x3b2;-catenin recruits the KAT3 transcriptional coactivator CREB-binding protein (CBP) or its closely related homolog, p300, as well as other components of the basal transcription machinery, to initiate transcription [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. As Kahn and colleagues reported, CBP/&#x3b2;-catenin-mediated transcription is essential for stem and/or progenitor cell maintenance and proliferation, whereas a switch to p300/&#x3b2;-catenin-mediated transcription is a critical step in the initiation of differentiation and a decrease in cellular potency [<xref ref-type="bibr" rid="B6">6</xref>]. In addition to regulating cellular processes, including proliferation, differentiation, motility, and survival, the canonical <italic>&#x3b2;</italic>-catenin-dependent Wnt signaling pathway plays crucial roles in embryonic development and maintenance of homeostasis in mature tissues [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>]. Wnt signaling is also involved in stem cell maintenance by modulating the levels of intrinsic pluripotency factors, for example, Oct4, Nanog, and Sox2 [<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>], and Wnt3a supplementation has been demonstrated to maintain the pluripotency of embryonic stem cells [<xref ref-type="bibr" rid="B16">16</xref>,&#x20;<xref ref-type="bibr" rid="B17">17</xref>].</p>
<p>Accumulating evidence suggests that the Wnt/&#x3b2;-catenin signaling pathway is often involved in oncogenesis and cancer development [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>]. The importance of aberrant Wnt signaling in some types of cancer, such as colorectal and breast cancer, is clear. In mice, it has long been known that misexpression of Wnt-1, -3, or -10 induces mammary adenocarcinomas [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>]. The APC<sup>Min</sup> mouse has also been shown to exhibit an enhanced incidence (&#x223c;10%) of spontaneous mammary cancer and a greatly increased susceptibility (90%) to carcinogen-induced mammary cancer [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>]. However, aberrant Wnt signaling may play a role in many other types of malignancies, even those without the classical mutations associated with the pathway. Our previous study reported that the HPV16 oncoproteins E6 and E7 reprogrammed HaCaT&#x20;cells and led to TIC formation by restoring Piwil2 expression [<xref ref-type="bibr" rid="B4">4</xref>]. We also observed that Piwil2 synchronously activated Wnt3a signaling to enhance reprogramming and maintain the stemness of TICs via the CBP/&#x3b2;-catenin interaction [data unpublished]. To explore the potential role of Wnt3a in the progression of cervical neoplasia, we investigated the expression of canonical Wnt3a signaling and related genes with microarray data set analysis and immunohistochemical staining of biopsied samples of normal cervix, low- and high-grade cervical intraepithelial neoplasia (CIN), and invasive cervical squamous cell carcinoma (SCC) tissue.</p>
<p>Our present findings provide novel pathological insights into Wnt3a signaling in the progression of CIN and aggressiveness of cervical cancer, thus defining a potential therapeutic target for cervical lesions.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Clinical Samples</title>
<p>The project was approved by the Ethics Committee of China-Japan Friendship Hospital (approval number: 2020&#x2013;28-K20). One hundred thirty-four histological specimens, including hysterectomy tissues and loop/cone biopsied samples, were retrieved from the files of the Department of Pathology of China-Japan Friendship Hospital. The specimens consisted of normal cervix (<italic>n</italic>&#x20;&#x3d; 20), CIN1 (<italic>n</italic>&#x20;&#x3d; 36), CIN2/3 (<italic>n</italic>&#x20;&#x3d; 32), and invasive SCC (<italic>n</italic>&#x20;&#x3d; 46) tissues.</p>
</sec>
<sec id="s2-2">
<title>Immunohistochemistry Analysis</title>
<p>Four-micrometer-thick formalin-fixed, paraffin-embedded tissue sections were deparaffinized with xylene and rehydrated through a graded series of ethanol. Antigen retrieval was performed with 0.01&#xa0;M citrate buffer (pH 6.0) in a microwave oven for 10&#xa0;min. After cooling to room temperature, the slides were incubated with 3% H<sub>2</sub>O<sub>2</sub> for 10&#xa0;min to inactivate endogenous peroxidase. The slices were incubated overnight at 4&#xb0;C in a humidified chamber with the following primary antibodies: 1:500 diluted anti-Wnt3a (ab28472), 1:500 diluted anti-&#x3b2;-catenin (ab32572), 1:1000 diluted anti-CBP (ab50702), 1:100 diluted anti-cytokeratin 17 (CK 17, ab53707), 1:1000 diluted anti-involucrin (ab53112), 1:200 diluted anti-CDKN2A/p16INK4&#x3b1; (p16, ab54210), and 1:200 diluted anti-Ki67 (ab16667). All of the primary antibodies were purchased from Abcam, United&#x20;States. The binding of the primary antibodies was visualized using the ChemMate detection kit (PV-9000, ZSBIO, China). The slices were lightly counterstained with Mayer&#x2019;s hematoxylin for 30&#xa0;s.</p>
<p>Immunoreactivity was semiquantitatively evaluated. The degree of positive staining for all antibodies was evaluated by score on a scale of 0&#x2013;3 for strength of intensity of staining and on a scale of 0&#x2013;4 for percentage of positive cells. The final total score was generated by the intensity score &#xd7; proportion score. The intensity score was defined as follows: 0, no staining of epithelial cells; 1, weak staining; 2, moderate staining; or 3, strong staining. The proportion score was defined as follows: 0, no staining of the cervical epithelial cells in any field; 1, &#x3c;10% of the epithelium stain-positive; 2, 11&#x2013;50% stain-positive; 3, 51&#x2013;80% stain-positive; or 4, &#x3e;80% stain-positive. The total score ranged from 0 to 12. Two different pathologists evaluated all the specimens in a blinded manner. Notably, the distribution of staining in the intraepithelial lesions (CIN1 and CIN2/3) was compared with that of the normal cervical squamous epithelium. CIN tissues were categorized as having the thickness of the samples being from two-thirds to fully stained.</p>
</sec>
<sec id="s2-3">
<title>Microarray and Gene Set Enrichment Analysis</title>
<p>To investigate the expression pattern of genes associated with the activation of Wnt/&#x3b2;-catenin signaling in the progression of cervical lesions, the data set GSE64217 (containing 2 normal cervix, 2 CIN2/3, and 2 cervical squamous cell cancer samples), GSE51993 (containing 7 HPV- normal cervix samples, 9 HPV &#x2b; CIN I samples and 8 HPV &#x2b; CIN III samples), GSE67522 (containing 11 HPV16- normal cervix samples, 11 HPV16&#x2b; non-malignants and 20 HPV16 &#x2b; cervical cancer tissues) were downloaded from the GEO database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>). The platforms for these data sets are all based on GPL10558 and an Illumina HumanHT-12 V4.0 Expression BeadChip. The downloaded files were processed using the R package and then calibrated, standardized, and converted to log2 data, or normalized with cubic spline method. The limma package was used to standardize the gene chip and analyze the differential expression. The quantile normalized values for canonical Wnt signaling pathway associated genes were found out via <italic>VLOOKUP</italic> from the gene expression description tables. Boxplot was used to show the expression difference among groups of normal cervix, CIN and&#x20;SCC.</p>
</sec>
<sec id="s2-4">
<title>Statistical Analyses</title>
<p>The data are presented as the means&#x20;&#xb1; SD. Statistical analyses were performed with SPSS version 25 (SPSS Inc., Chicago, IL, United&#x20;States). The significance of gene expression between groups in microarray data sets were analyzed with one-way analysis of variance. The comparison of immunoreactivity score between normal cervix and cervical lesions were performed with two-tailed Chi-square test. Pearson test was used to analyze the correlation between the expression of the biomarkers and the cervical lesion degree. A <italic>p</italic> value &#x3c;0.05 was considered significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Expression Pattern of Canonical Wnt Pathway-Related Genes</title>
<p>To identify the differentially expressed genes (DEGs), the data set GSE64217, GSE51993 and GSE67522 were analyzed by the GEO2R method on the GEO website. The boxplot of the distribution of the normalized expression values for selected samples demonstrates that the data were suitable for the analysis and &#x201c;limma&#x201d; (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>), which was used to perform a top table computation to extract a list of the top-ranked genes. Within the top 250 differentially expressed genes, the canonical Wnt signaling genes <italic>Wnt3a</italic>, <italic>CTNNB1 (&#x3b2;-catenin)</italic>, and <italic>CREBBP (CBP)</italic> were significantly upregulated in the samples of precancerous and cancer of the cervix compared with those of the normal cervix, thereby contributing to the distinct upregulation of their downstream transcription factors <italic>KLF4</italic>, <italic>MYC</italic>, and <italic>SOX2</italic>, except <italic>KLF4</italic> slightly downregulated in CIN (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). As previously reported, CBP/&#x3b2;-catenin signaling is important for the maintenance of stem cell pluripotency [<xref ref-type="bibr" rid="B6">6</xref>]. <italic>KRT17 (CK17)</italic>, <italic>TP63</italic> and <italic>CDK2A (P16)</italic>, markers of HPV target cells/cervical cancer stem cells (CSCs), were apparently upregulated in CIN and SCC. In contrast, markers of squamous cell differentiation, <italic>LORICRIN</italic>, <italic>INVOLUCRIN</italic> and <italic>KRT4 (CK4),</italic> were significantly downregulated in CIN and SCC (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). It was somewhat unusual that <italic>KRT14 (CK14)</italic> and <italic>KLF4,</italic> showed in these GSE gene sets, were moderately downregulated in CIN tissues compared with normal cervix, nevertheless they were all significantly upregulated in SCC tissues (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The bioinformatics analyses of the microarray data sets of GSE64217, GSE51993 and GSE67522 containing normal cervix, CIN, and SCC sample information <bold>(A)</bold> Boxplot of the distribution of normalized expression values <bold>(B)</bold> The microarray data sets of GSE64217, GSE51993 and GSE67522 were analyzed by GEO2R on GEO database. <italic>Wnt3a/CTNNB1/CREBBP</italic> and their target genes <italic>MYC</italic> and <italic>SOX2</italic> showed higher expression levels in CIN and SCC than in normal cervix. The stemness-associated markers were significantly upregulated, while the cell differentiation markers were notably downregulated in CIN and SCC. The expression values of KLF4 and CK14 decreased moderately in CIN as compared with normal cervix. CIN and SCC compared with normal cervix, &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01.</p>
</caption>
<graphic xlink:href="pore-27-609620-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Wnt3a/&#x3b2;-Catenin/CBP Expression and Cervical Lesion Grade</title>
<p>In normal cervical squamous epithelium, Wnt3a staining was confined to the basal cells, whereas in CIN1 diffuse immunoreactivity was limited to the lower one-third of the epithelial layer, and in CIN2/3, the staining extended through the full thickness of the epithelial layer (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Strong to moderate Wnt3a immunoreactivity was observed in 45 (97.8%) of 46 invasive SCCs and 26 (81.3%) of 32 CIN2/3, while 44.4% (16/36) CIN1 showed light-to-moderate expression, as occasional scattered staining was observed within basal cells in normal cervix that was considered negative (<xref ref-type="table" rid="T1">Table&#x20;1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Immunohistochemical expression pattern of Wnt3a, <italic>&#x3b2;</italic>-catenin and CBP in normal cervix, CIN1, CIN2/3, and SCC tissue. In the normal cervix, Wnt3a-, <italic>&#x3b2;</italic>-catenin- and CBP-positive cells scattering was confined to the basal cell layer. The immunoreactivity score of Wnt3a and CBP gradually increased, and <italic>&#x3b2;</italic>-catenin staining showed a notable positive translocation from the membrane to the cytoplasm and nucleus during the progression from CIN1 to SCC <bold>(A)</bold>. The total scores of Wnt3a, <italic>&#x3b2;</italic>-catenin and CBP immunoreactivity were significantly higher in CIN2/3 and cervical cancer tissues compared to the normal cervix and CIN1 tissues, respectively <bold>(B)</bold>. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01; Bar, 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="pore-27-609620-g002.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Relationship between Wnt3a/&#x3b2;-catenin/CBP and lesion grade of cervical squamous epithelium (n&#x3d;134).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Pathologic diagnosis</th>
<th rowspan="2" align="center">
<italic>N</italic>
</th>
<th colspan="3" align="center">Wnt3a</th>
<th colspan="3" align="center">&#x3b2;-catenin</th>
<th colspan="3" align="center">CBP</th>
</tr>
<tr>
<th align="center">Positive<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> (%)</th>
<th align="center">
<italic>&#x3c7;</italic>
<sup>2</sup>
</th>
<th align="center">
<italic>p</italic>
</th>
<th align="center">Positive<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> (%)</th>
<th align="center">
<italic>&#x3c7;</italic>
<sup>2</sup>
</th>
<th align="center">
<italic>p</italic>
</th>
<th align="center">Positive<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> (%)</th>
<th align="center">
<italic>&#x3c7;</italic>
<sup>2</sup>
</th>
<th align="center">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Normal cervix</td>
<td align="center">20</td>
<td align="center">0</td>
<td align="center">69.263<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">&#x3c;0.01<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">1 (5%)</td>
<td align="center">40.504<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">&#x3c;0.01<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">2 (10%)</td>
<td align="center">21.484<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="center">&#x3c;0.01<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">CIN1</td>
<td align="center">36</td>
<td align="center">16 (44.4%)</td>
<td rowspan="3" align="center">32.438<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td rowspan="3" align="center">&#x3c;0.01<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="center">18 (50%)</td>
<td rowspan="3" align="center">11.735<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td rowspan="3" align="center">&#x3c;0.01<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="center">18 (50%)</td>
<td rowspan="3" align="center">7.195<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td rowspan="3" align="center">&#x3c;0.05<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">CIN2/3</td>
<td align="center">32</td>
<td align="center">26 (81.3%)</td>
<td align="center">23 (71.9%)</td>
<td align="center">20 (62.5%)</td>
</tr>
<tr>
<td align="left">Cervical cancer</td>
<td align="center">46</td>
<td align="center">45 (97.8%)</td>
<td align="center">39 (84.8%)</td>
<td align="center">36 (78.3%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>
<sup>a</sup>
</label>
<p>Positive staining surpassed the basal&#x20;cells.</p>
</fn>
<fn id="Tfn2">
<label>
<sup>b</sup>
</label>
<p>Chi square test among groups of normal cervix, CIN1, CIN2/3, and cervical cancer.</p>
</fn>
<fn id="Tfn3">
<label>
<sup>c</sup>
</label>
<p>Chi square test among lesion groups.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A gradual increase in the <italic>&#x3b2;</italic>-catenin score and its positive translocation from the membrane to the cytoplasm and finally to the nucleus was noted in cervical lesions at higher stages (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Only 5% (1/20) of the normal cervix samples were membrane positive for <italic>&#x3b2;</italic>-catenin in the parabasal cells, while one-half (18/36) of the CIN1 samples were membrane positive for <italic>&#x3b2;</italic>-catenin. Approximately 71.9% (23/32) of the CIN2/3 and 84.8% (39/46) of the SCC samples had cytoplasmic and even nuclear positive staining. The pattern of CBP expression in each stage of cervical lesion was similar to that of <italic>&#x3b2;</italic>-catenin with only nuclear immunoreactivity (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). Overall, the total scores of Wnt3a, <italic>&#x3b2;</italic>-catenin and CBP immunoreactivity were significantly higher in CIN2/3 and cervical cancer tissues compared to the normal cervix and CIN1 tissues, respectively (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>, <italic>p</italic>&#x20;&#x3c;&#x20;0.01).</p>
</sec>
<sec id="s3-3">
<title>Wnt Signaling Activation Promotes Lesion Progression</title>
<p>Markers useful in the assessment of lesion grade were further observed. P16, which is valuable in the diagnosis of high-grade CIN, was positively stained in the upper two-thirds and full thickness of the epithelium in most cases of CIN2/3 and in all of cervical cancer tissues, while minimal or negative P16 was observed in cervical squamous epithelium of the normal cervix or CIN1 samples (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). As the Ki67 antigen is expressed in all active phases of the cell cycle, diffuse immunoreactivity was distributed throughout SCC and the full thickness of the CIN2/3 samples, while scattered positive staining was confined to only the lower one-third of the CIN1 and the basal cells in the normal cervix samples (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Statistical analysis showed that the IHC scores of P16 and Ki67 were significantly higher in both the CIN2/3 and SCC tissues compared to the CIN1 and normal cervix (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>, <italic>p</italic>&#x20;&#x3c;&#x20;0.01).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Representative images of P16 and Ki67 immunostaining in normal cervix, CIN1, CIN2/3, and SCC tissue <bold>(A)</bold> P16 was negative in the normal cervix and CIN1 samples. Scattered Ki67 positivity was confined to the basal cells in the normal cervix but in both the basal and parabasal cells in the CIN1 samples. Diffuse immunoreactivity of P16 and Ki67 was distributed in the SCC and full thickness of the CIN2/3 samples <bold>(B)</bold> The IHC scores of P16 and Ki67 were significantly higher in both the CIN2/3 and SCC tissues compared to the CIN1 and normal cervix. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01; Bar, 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="pore-27-609620-g003.tif"/>
</fig>
<p>In this work, the characterization of <italic>&#x3b2;</italic>-catenin and coactivator CBP expression implied that the canonical Wnt signaling pathway was activated in high-grade lesions. Consistent with previous studies, CBP-Wnt activity was associated with tumorigenesis and stem cell maintenance because it modulates the levels of intrinsic pluripotency factors, such as Oct4, Nanog, and Sox2 [<xref ref-type="bibr" rid="B6">6</xref>]. Here, CK17, a marker of reserve cells and TICs [<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>], was expressed in the basal compartment of the normal cervix and CIN1 samples, while it displayed diffuse immunoreactivity in the SCC and CIN2/3 samples (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>). On the other hand, the differentiation marker Involucrin was extensively expressed in the upper two-thirds of the squamous epithelium in the normal cervix and CIN1 samples, while minimal immunoreactivity was observed in the CIN2/3 or SCC samples (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Representative images of CK17 and Involucrin immunostaining in normal cervix, CIN1, CIN2/3, and SCC tissues <bold>(A)</bold> The reserve cells in the basal layer were positive for CK17 in the normal cervix. The full thickness of the CIN2/3 and SCC samples showed CK17 staining, whereas only a very small number of positive cells were scattered in the lower one-third of the squamous epithelium in the CIN1 samples. In contrast to the pattern of CK17 expression, diffuse immunoreactivity of Involucrin was observed in the full thickness of the normal cervix and CIN1 samples, whereas minimal and negative Involucrin expression was observed in the CIN2/3 and SCC tissue <bold>(B)</bold> The IHC score of CK17 increased gradually in accord with the lesion grade, while the score of Involucrin staining was significantly lower in SCC than that in normal cervix and CIN lesions. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01; Bar, 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="pore-27-609620-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Correlation Between the Expression of Various Biomarkers With the Cervical Lesion Grade</title>
<p>The heatmap, which was made with the total IHC scores of various biomarkers and the cervical lesion grade, apparently displayed the association between them (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>). Spearman test further verified that the expression of Wnt3a, <italic>&#x3b2;</italic>-catenin, CBP, P16, Ki67, and CK17 were positively correlated with the cervical lesion grade (<italic>r</italic>&#x20;&#x3d; 0.679, 0.577, 0.688, 0.898, 0.892, 0.867, respectively, all <italic>p</italic> value &#x3c;0.01), while the expression of Involucrin was negatively correlated with it (<italic>r</italic>&#x20;&#x3d; &#x2212;0.557, <italic>p</italic>&#x20;&#x3c; 0.01) (<xref ref-type="table" rid="T2">Table&#x20;2</xref>). Taken together, these data suggest that Wnt/&#x3b2;-catenin/CBP is activated in CIN2/3 lesions and SCC, where it maintains TIC pluripotency and promotes cell proliferation, thereby contributing to neoplastic development.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Wnt signaling pathway activation and cervical lesion progression <bold>(A)</bold> The heat map, which was made with the total IHC scores of various biomarkers and the cervical lesion grade, apparently showed the trends of Wnt/&#x3b2;-catenin/CBP-regulated gene expression in the process of cervical lesion <bold>(B)</bold> Model of Wnt3a activation promoting the transition from HR-HPV-infected cervix to cervical cancer.</p>
</caption>
<graphic xlink:href="pore-27-609620-g005.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Correlation between the expression of various biomarkers and the cervical lesion&#x20;grade.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left"/>
<th colspan="7" align="center">Total immunoreactivity scores</th>
</tr>
<tr>
<th align="center">Wnt3a</th>
<th align="center">&#x3b2;-catenin</th>
<th align="center">CBP</th>
<th align="center">P16</th>
<th align="center">Ki67</th>
<th align="center">CK17</th>
<th align="center">Involucrin</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="8" align="left">Cervical lesion grade</td>
</tr>
<tr>
<td align="center">&#x2003;Correlation coefficient</td>
<td align="center">0.679</td>
<td align="center">0.577</td>
<td align="center">0.688</td>
<td align="center">0.898</td>
<td align="center">0.892</td>
<td align="center">0.867</td>
<td align="center">&#x2212;0.557</td>
</tr>
<tr>
<td align="left">&#x2003;<italic>p</italic> Value</td>
<td align="center">&#x3c;0.01</td>
<td align="center">&#x3c;0.01</td>
<td align="center">&#x3c;0.01</td>
<td align="center">&#x3c;0.01</td>
<td align="center">&#x3c;0.01</td>
<td align="center">&#x3c;0.01</td>
<td align="center">&#x3c;0.01</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this report, we described the identification of canonical Wnt signaling activation in precancerous lesions and cervical cancer. Wnt proteins comprise a large family of secreted growth factors that play essential roles in regulating cell proliferation, survival, differentiation, tissue architecture, and organogenesis during embryonic development [<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>]. Accumulating evidence suggests that the Wnt/&#x3b2;-catenin signaling pathway serves critical functions in the sequential development of the neoplastic process from initiation, proliferation and transformation in a broad range of cancer types, such as colorectal, breast, and cervical cancer [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>]. The activation of the canonical Wnt pathway is characterized by the accumulation of <italic>&#x3b2;</italic>-catenin in the cytoplasm and nucleus; nevertheless, <italic>&#x3b2;</italic>-catenin is mainly located at cellular junctions in the absence of Wnt ligands [<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>].</p>
<p>In this study, the gene expression profile data showed that within the top 250 differentially expressed genes, the canonical Wnt signaling genes <italic>Wnt3a</italic>, <italic>&#x3b2;-catenin</italic>, and <italic>CBP</italic> were significantly upregulated in the CIN lesion and cervical cancer samples compared with those in the normal cervix sample. These bioinformatics data were further verified by immunohistochemical staining. In particular, a gradual increase in the <italic>&#x3b2;</italic>-catenin immunoreactivity score and its positive translocation from the membrane to the cytoplasm and finally to the nucleus were observed in CIN2/3 and SCC, which indicates the activation of Wnt signaling [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B12">12</xref>]. These excess <italic>&#x3b2;</italic>-catenin translocated to the nucleus and activated the downstream genes expression, including c-Myc, Sox2, Nanog, Oct4, Survivin and Cyclin D1, thus contributing to oncogenesis and cancer development [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B27">27</xref>,&#x20;<xref ref-type="bibr" rid="B31">31</xref>].</p>
<p>The physical association between <italic>&#x3b2;</italic>-catenin and CBP/p300, which are cotranscriptional factors, influences Wnt/&#x3b2;-catenin signaling [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B32">32</xref>]. CBP-mediated Wnt activity is essential for cell proliferation and pluripotency and has a central role in advanced stages of neoplastic development [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B33">33</xref>], whereas p300/&#x3b2;-catenin-mediated transcription is the critical step in initiating differentiation and decreasing cellular potency [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B34">34</xref>]. The activation of CBP/&#x3b2;-catenin is deemed the default active pathway in stem cells, which maintains an undifferentiated proliferative state [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>]. For regular development to proceed, cells must exit the cell cycle and initiate the process of differentiation [<xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>]. The array data analysis performed with GEO2R showed that the expression of <italic>CBP/&#x3b2;-catenin</italic> and its target genes of <italic>KLF4</italic>, <italic>MYC</italic>, and <italic>SOX2</italic> were upregulated, generally synchronicity with the progression of cervical lesion grade. Consistent with the activation of CBP/&#x3b2;-catenin, markers of TICs <italic>CK17</italic>, <italic>CK14</italic>, <italic>TP63</italic> and <italic>P16</italic> were upregulated, while markers of squamous cell differentiation <italic>LORICRIN</italic>, <italic>INVOLUCRIN</italic> and <italic>CK4</italic> were downregulated significantly in the CIN and SCC samples compared with normal cervix samples. However, the expression of <italic>KLF4</italic> and <italic>CK14</italic> were slightly decreased in CIN as compared with normal cervix. We speculated that the lesion grade (CIN1 or CIN2/3) and the status of high-risk HPV infection in CIN samples, to some extent, may interfere the results. The immunoreactivity scores analyzed with Spearman test showed that the expression of Ki67, P16, CK17 were positively correlated with the cervical lesion degree while Involucrin was just the opposite. Thus, both array and IHC data further verified that canonical Wnt signaling activation promotes cervical lesion progression, which indicates the potential role of Wnt3a in maintaining stemness of TICs reprogrammed by Piwil2 in our previous report and sequentially triggering the progression of CIN2/3 and SCC [<xref ref-type="bibr" rid="B4">4</xref>]. Furthermore, inhibiting the CBP/&#x3b2;-catenin interaction with specific antagonists (i.e.,&#x20;ICG-001 or PRI-724) led to symmetric CSC divisions at the expense of asymmetric divisions; thus, CSCs are stochastically cleared from their niche via symmetric differentiative division [<xref ref-type="bibr" rid="B40">40</xref>&#x2013;<xref ref-type="bibr" rid="B42">42</xref>]. Therefore, selectively antagonizing the CBP/&#x3b2;-catenin interaction may be a potential target for CIN2/3 and SCC therapy.</p>
<p>In conclusion, our observations demonstrate that the canonical Wnt signaling pathway was activated during the oncogenesis of cervical lesions. The CBP/&#x3b2;-catenin interaction played an essential role in the progression of CIN and SCC by maintaining the stemness of TICs (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). Therefore, targeting the CBP/&#x3b2;-catenin interaction may be a promising therapeutic strategy for preventing CIN progression.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of China-Japan Friendship Hospital (approval number: 2020-28-K20). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>DQF performed bioinformatics analysis. JL, WHW, HYL, JL, and HY carried out immunohistochemistry staining. KQY and BL analyzed the experimental results. All authors wrote and revised the manusript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Key R&#x26;D Program of China (2018YFC1003900), the National Natural Science Foundation of China (81372777, 81372779), and the Fundamental Research Funds for the Central Universities and Research projects on biomedical transformation of China-Japan Friendship Hospital (No. PYBZ1827).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chibwesha</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Stringer</surname>
<given-names>JSA</given-names>
</name>
</person-group>. <article-title>Cervical cancer as a global concern</article-title>. <source>JAMA</source> (<year>2019</year>) <volume>322</volume>(<issue>16</issue>):<fpage>1558</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2019.16176</pub-id> </citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baade</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Cancer statistics in China, 2015</article-title>. <source>CA: A Cancer J&#x20;Clinicians</source> (<year>2016</year>) <volume>66</volume>(<issue>2</issue>):<fpage>115</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21338</pub-id> </citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferenczy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Persistent human papillomavirus infection and cervical neoplasia</article-title>. <source>Lancet Oncol</source> (<year>2002</year>) <volume>3</volume>(<issue>1</issue>):<fpage>11</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/s1470-2045(01)00617-9</pub-id> </citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group> <article-title>Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis</article-title>. <source>Oncotarget</source> (<year>2016</year>) <volume>7</volume>(<issue>40</issue>):<fpage>64575</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.11810</pub-id> </citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pakula</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
</person-group>. <article-title>A tale of two signals: AR and WNT in development and tumorigenesis of prostate and mammary gland</article-title>. <source>Cancers</source> (<year>2017</year>) <volume>9</volume>(<issue>2</issue>):<fpage>14</fpage>. <pub-id pub-id-type="doi">10.3390/cancers9020014</pub-id> </citation>
</ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Wnt signaling in stem cells and cancer stem cells: a tale of two coactivators</article-title>. <source>Prog Mol Biol Transl Sci</source> (<year>2018</year>) <volume>153</volume>:<fpage>209</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmbts.2017.11.007</pub-id> </citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Janda</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>GXY</given-names>
</name>
<name>
<surname>Larkin</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>VC</given-names>
</name>
<etal/>
</person-group> <article-title>Non-equivalence of Wnt and R-spondin ligands during Lgr5&#x2b; intestinal stem-cell self-renewal</article-title>. <source>Nature</source> (<year>2017</year>) <volume>545</volume>(<issue>7653</issue>):<fpage>238</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/nature22313</pub-id> </citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doumpas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lampart</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Lentini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nestor</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Cant&#xf9;</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>TCF/LEF dependent and independent transcriptional regulation of Wnt/&#x3b2;&#x2010;catenin target genes</article-title>. <source>EMBO J</source> (<year>2019</year>) <volume>38</volume>(<issue>2</issue>). <pub-id pub-id-type="doi">10.15252/embj.201798873</pub-id> </citation>
</ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukaszewicz</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Melendez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Teo</surname>
<given-names>J-L</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>KKY</given-names>
</name>
<etal/>
</person-group> <article-title>The mode of stem cell division is dependent on the differential interaction of &#x3b2;-catenin with the Kat3 coactivators CBP or p300</article-title>. <source>Cancers</source> (<year>2019</year>) <volume>11</volume>(<issue>7</issue>):<fpage>962</fpage>. <pub-id pub-id-type="doi">10.3390/cancers11070962</pub-id> </citation>
</ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rieger</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sunohara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>p300/&#x3b2;-Catenin interactions regulate adult progenitor cell differentiation downstream of WNT5a/protein kinase C (PKC)</article-title>. <source>J&#x20;Biol Chem</source> (<year>2016</year>) <volume>291</volume>(<issue>12</issue>):<fpage>6569</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.706416</pub-id> </citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmeyer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Raggioli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rudloff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anton</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hierholzer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Del Valle</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Wnt/-catenin signaling regulates telomerase in stem cells and cancer cells</article-title>. <source>Science</source> (<year>2012</year>) <volume>336</volume>(<issue>6088</issue>):<fpage>1549</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1126/science.1218370</pub-id> </citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Peifer</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Wnt/Beta-catenin signaling regulation and a role for biomolecular condensates</article-title>. <source>Develop Cel</source> (<year>2019</year>) <volume>48</volume>(<issue>4</issue>):<fpage>429</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2019.01.025</pub-id> </citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martins-Neves</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Corver</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Paiva-Oliveira</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>van den Akker</surname>
<given-names>BEWM</given-names>
</name>
<name>
<surname>Briaire-de-Bruijn</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Bov&#xe9;e</surname>
<given-names>JVMG</given-names>
</name>
<etal/>
</person-group> <article-title>Osteosarcoma stem cells have active wnt/&#x3b2;-catenin and overexpress SOX2 and KLF4</article-title>. <source>J&#x20;Cel Physiol</source> (<year>2016</year>) <volume>231</volume>(<issue>4</issue>):<fpage>876</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.25179</pub-id> </citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trisno</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Philo</surname>
<given-names>KED</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Cat&#xe1;</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ruiz-Torres</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rankin</surname>
<given-names>SA</given-names>
</name>
<etal/>
</person-group> <article-title>Esophageal organoids from human pluripotent stem cells delineate Sox2 functions during esophageal specification</article-title>. <source>Cell Stem Cell</source> (<year>2018</year>) <volume>23</volume>(<issue>4</issue>):<fpage>501</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2018.08.008</pub-id> </citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y-F</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Helicobacter pylori upregulates Nanog and Oct4 via Wnt/&#x3b2;-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer</article-title>. <source>Cancer Lett</source> (<year>2016</year>) <volume>374</volume>(<issue>2</issue>):<fpage>292</fpage>&#x2013;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2016.02.032</pub-id> </citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishinakamura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Iwamatsu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimosato</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells</article-title>. <source>Biochem Biophysical Res Commun</source> (<year>2006</year>) <volume>343</volume>(<issue>1</issue>):<fpage>159</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.02.127</pub-id> </citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zandi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muzaffar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kaushik</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Palta</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>WNT3A signalling pathway in buffalo (Bubalus bubalis) embryonic stem cells</article-title>. <source>Reprod Fertil Dev</source> (<year>2014</year>) <volume>26</volume>(<issue>4</issue>):<fpage>551</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1071/RD13084</pub-id> </citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nourbakhsh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mansoor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koro</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Minoo</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Expression profiling reveals involvement of WNT pathway in the malignant progression of sessile serrated adenomas</article-title>. <source>Am J&#x20;Pathol</source> (<year>2019</year>) <volume>189</volume>(<issue>9</issue>):<fpage>1732</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2019.05.009</pub-id> </citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Leder</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice</article-title>. <source>Oncogene</source> (<year>1997</year>) <volume>15</volume>(<issue>18</issue>):<fpage>2133</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1201593</pub-id> </citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Gavin</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>AP</given-names>
</name>
</person-group>. <article-title>Differential transformation of mammary epithelial cells by Wnt genes</article-title>. <source>Mol Cel Biol.</source> (<year>1994</year>) <volume>14</volume>(<issue>9</issue>):<fpage>6278</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.14.9.6278</pub-id> </citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuang</surname>
<given-names>S-M</given-names>
</name>
<name>
<surname>Wiseman</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>S&#xf6;derkvist</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Frequent mutations of the Trp53, Hras1 and &#x3b2;-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice</article-title>. <source>Oncogene</source> (<year>2002</year>) <volume>21</volume>(<issue>36</issue>):<fpage>5643</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1205649</pub-id> </citation>
</ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moser</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Mattes</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Dove</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Lindstrom</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Haag</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>MN</given-names>
</name>
</person-group>. <article-title>ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias</article-title>. <source>Proc Natl Acad Sci</source> (<year>1993</year>) <volume>90</volume>(<issue>19</issue>):<fpage>8977</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.90.19.8977</pub-id> </citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martens</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Arends</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van der Linden</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>De Boer</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Helmerhorst</surname>
<given-names>TJ</given-names>
</name>
</person-group>. <article-title>Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell</article-title>. <source>Anticancer Res</source> (<year>2004</year>) <volume>24</volume>(<issue>2B</issue>):<fpage>771</fpage>&#x2013;<lpage>5</lpage>. </citation>
</ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz-S&#xe1;nchez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Santiago-L&#xf3;pez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cruz-Dom&#xed;nguez</surname>
<given-names>VB</given-names>
</name>
<name>
<surname>Toledo-Guzm&#xe1;n</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Cueto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mu&#xf1;iz-Hern&#xe1;ndez</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression</article-title>. <source>Oncotarget</source> (<year>2016</year>) <volume>7</volume>(<issue>22</issue>):<fpage>31943</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.8218</pub-id> </citation>
</ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ambrosi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wandmacher</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rauscher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Betge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rindtorff</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>(<issue>1</issue>):<fpage>2197</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09898-0</pub-id> </citation>
</ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X-F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X-Y</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>P-S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W-T</given-names>
</name>
</person-group>. <article-title>DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/&#x3b2;-catenin pathway via GSK3&#x3b2;</article-title>. <source>Cell Death Dis</source> (<year>2018</year>) <volume>9</volume>(<issue>3</issue>):<fpage>339</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-018-0359-6</pub-id> </citation>
</ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J-Z</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Overexpression of MUC13, a poor prognostic predictor, promotes cell growth by activating Wnt signaling in hepatocellular carcinoma</article-title>. <source>Am J&#x20;Pathol</source> (<year>2018</year>) <volume>188</volume>(<issue>2</issue>):<fpage>378</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2017.10.016</pub-id> </citation>
</ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayala-Calvillo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mojica-V&#xe1;zquez</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Garc&#xed;a-Carranc&#xe1;</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Maya</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Wnt/&#x3b2;catenin pathway activation and silencing of the APC gene in HPVpositive human cervical cancerderived cells</article-title>. <source>Mol Med Rep</source> (<year>2018</year>) <volume>17</volume>(<issue>1</issue>):<fpage>200</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2017.7853</pub-id> </citation>
</ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>S-J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WH</given-names>
</name>
<etal/>
</person-group> <article-title>Cell cycle regulators, APC/&#x3b2;-catenin, NF-&#x3ba;B and Epstein-Barr virus in gastric carcinomas</article-title>. <source>Pathology</source> (<year>2010</year>) <volume>42</volume>(<issue>1</issue>):<fpage>58</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.3109/00313020903356392</pub-id> </citation>
</ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xdc;ren</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fallen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Usub&#xfc;t&#xfc;n</surname>
<given-names>A</given-names>
</name>
<name>
<surname>K&#xfc;&#xe7;&#xfc;kali</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schlegel</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression</article-title>. <source>Cancer Res</source> (<year>2005</year>) <volume>65</volume>(<issue>14</issue>):<fpage>6199</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0455</pub-id> </citation>
</ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gang</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>Y-T</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Huantes</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia</article-title>. <source>Oncogene</source> (<year>2014</year>) <volume>33</volume>(<issue>17</issue>):<fpage>2169</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2013.169</pub-id> </citation>
</ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sutter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Blauwkamp</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cadigan</surname>
<given-names>KM</given-names>
</name>
</person-group>. <article-title>CBP/p300 are bimodal regulators of Wnt signaling</article-title>. <source>EMBO J</source> (<year>2007</year>) <volume>26</volume>(<issue>9</issue>):<fpage>2284</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601667</pub-id> </citation>
</ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bordonaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lazarova</surname>
<given-names>DL</given-names>
</name>
</person-group>. <article-title>CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer</article-title>. <source>Wjg</source> (<year>2015</year>) <volume>21</volume>(<issue>27</issue>):<fpage>8238</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v21.i27.8238</pub-id> </citation>
</ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bordonaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lazarova</surname>
<given-names>DL</given-names>
</name>
</person-group>. <article-title>Determination of the role of CBP- and p300-mediated Wnt signaling on colonic cells</article-title>. <source>JMIR Res Protoc</source> (<year>2016</year>) <volume>5</volume>(<issue>2</issue>):<fpage>e66</fpage>. <pub-id pub-id-type="doi">10.2196/resprot.5495</pub-id> </citation>
</ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ring</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y-M</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Wnt/catenin signaling in adult stem cell physiology and disease</article-title>. <source>Stem Cel Rev Rep</source> (<year>2014</year>) <volume>10</volume>(<issue>4</issue>):<fpage>512</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1007/s12015-014-9515-2</pub-id> </citation>
</ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malleske</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jr, Lallier</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>SD</given-names>
</name>
</person-group>. <article-title>Regulation of human airway epithelial tissue stem cell differentiation by &#x3b2;-catenin, P300, and CBP</article-title>. <source>Stem Cells</source> (<year>2018</year>) <volume>36</volume>(<issue>12</issue>):<fpage>1905</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1002/stem.2906</pub-id> </citation>
</ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakoby</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schnittger</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Cell cycle and differentiation</article-title>. <source>Curr Opin Plant Biol</source> (<year>2004</year>) <volume>7</volume>(<issue>6</issue>):<fpage>661</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbi.2004.09.015</pub-id> </citation>
</ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Candido</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Pilarz</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Sicinska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bronson</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Bowden</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2017</year>) <volume>114</volume>(<issue>40</issue>):<fpage>10660</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1702914114</pub-id> </citation>
</ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>The role of E2F1-topoII&#x3b2; signaling in regulation of cell cycle exit and neuronal differentiation of human SH-SY5Y cells</article-title>. <source>Differentiation</source> (<year>2018</year>) <volume>104</volume>:<fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.diff.2018.07.002</pub-id> </citation>
</ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Symmetric division versus asymmetric division: a tale of two coactivators</article-title>. <source>Future Med Chem</source> (<year>2011</year>) <volume>3</volume>(<issue>14</issue>):<fpage>1745</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.4155/fmc.11.126</pub-id> </citation>
</ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Berlind</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mavila</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells</article-title>. <source>Cell Commun Signal</source> (<year>2018</year>) <volume>16</volume>(<issue>1</issue>):<fpage>9</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-018-0222-5</pub-id> </citation>
</ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>JCY</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>TTC</given-names>
</name>
<name>
<surname>Ngan</surname>
<given-names>RKC</given-names>
</name>
<etal/>
</person-group> <article-title>Therapeutic targeting of CBP/&#x3b2;-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin</article-title>. <source>Sci Rep</source> (<year>2015</year>) <volume>5</volume>:<fpage>9979</fpage>. <pub-id pub-id-type="doi">10.1038/srep09979</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>